Image

Plasma Biomarker in Amblyopia Patients

Plasma Biomarker in Amblyopia Patients

Recruiting
3-12 years
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

This prospective study aims to observe the predictive effect of peripheral blood plasma biomarker on the outcome of treatment in children with different types of amblyopia. We also investigated the mechanism of neuromodulation in the visual development of amblyopic children.

Eligibility

Inclusion Criteria:

  • Diagnosed with amblyopia
  • 3-12 years of age
  • Able to tolerate amblyopia treatment
  • Agree to be involved in this study and agree to have a follow up visit every 3 months.

Exclusion Criteria:

  • Have previous treatment history before
  • Have pathological ocular anomalies known to cause reduced visual acuity
  • Have previous psychiatric, visual or neurological disorders
  • Have eccentric fixation and/or abnormal retinal correspondence
  • Have attention disorder and learning disability that cannot comprehend psychophysical test instructions given and/or consent for themselves

Study details
    Amblyopia

NCT05705778

Zhongshan Ophthalmic Center, Sun Yat-sen University

25 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.